Founder Partner Capital Zhou Wei: Focus On Investment Platform Opportunities And Technology Companies

"We will continue to focus on cutting-edge science and technology, industrial Internet, digital medicine, and consumption of new people. In particular, the epidemic has accelerated the development of digital medical industry, which will be our key and deep-seated field." Recently, Zhou Wei, executive partner of Founder partners capital, said in an exclusive interview with 21st century economic reporter.

Chuangshi partner capital was founded in 2017 by Zhou Wei, the former managing partner of KPCB, and the TMT team that has worked together for many years. The team's early investment companies include Jingdong, Yixin, rong360, Himalaya, etc., creating a success rate of 30% Unicorn projects invested in the early 10 years.

In the more than three years since the establishment of the new brand, Chuangshi partners have invested in several star cases, such as Shukun technology, Xiaomei mobile, Bingjian technology and hongsong classroom, and obtained two IPOs - wanjiayilian (1762. HK) and Kecheng shares (SH: 605183).

"From KPCB to founding partner CCV, we have experienced several cycles and black swan events in our investment career in the past 14 years, but the core investment strategy and playing method will not be affected by external changes. Investing in platform based opportunities and technology-based companies is our special focus and uniqueness. " Zhou Wei said.

In Zhou Wei's view, 2020 is a turning point in the development of venture capital industry. For investment institutions, they need to expand from investing in Internet projects to investing in high-tech and more future development projects. Investment in advanced technology will be the key to the next stage of venture capital. For entrepreneurs, they should also change from jobs to musk, which will make it easier for them to win the favor of investors.

In 2020, overfulfilling the second phase of US dollar fundraising is another milestone for founding partners. Zhou Wei said that the team was able to successfully complete the fund-raising during the severe epidemic period from January to September 2020 mainly because of three key points. First, the data of projects invested by the team in the past is very solid. Second, in the case of remote communication, quickly establish mutual trust and mutual understanding.

Third, we should make bold decisions. The team once told LP that no matter how much money it got at the end of September, it would close the financing, so as to spend more time and energy on investment. This allows the truly confident LP to speed up the process of investment decision-making.

Looking forward to the new year, Zhou Wei said: first of all, the team attaches great importance to the digital medical track. This industry is developing very rapidly with the promotion of AI, robotics and other technologies, as well as the impact of the epidemic. In January 2021, Chuangshi partners just announced the investment of Ruihua Kangyuan, which is a comprehensive hiot solution for smart hospitals. In 2019 and 2020, Chuangshi partners have continued to invest more in Shukun technology.

"Second, we are optimistic about using the Chinese way to build cloud and SaaS companies. The American way is pure SaaS, but the Chinese companies we invest in are more deeply involved in the industry process. Through technology, we can reshape the industry chain and improve production efficiency and efficiency." Zhou Wei said.

Third, pure to C also has investment opportunities. Zhou Wei said that the team is very concerned about the needs of the new group. The new group not only refers to the millennials, but also includes the silver haired people. The team has invested in companies that are vertically and accurately oriented to new groups, and continues to be optimistic about the DTC model and the future development space of platform companies.